Atlas Trials

Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic Cholangiocarcinoma

Clinical trial NCT04077983 · UNKNOWN

Trial details

NCT number
NCT04077983
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cholangiocarcinoma, Intrahepatic
Start date
2019-09-01
Primary completion
2020-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.